Maryam Heidarpour

Maryam Heidarpour

Auto-generated profile, based on publicly available information

Maryam Heidarpour

Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2020 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
MHMaryam Heidarpour
Maryam Heidarpour
MVMehrbod Vakhshoori
Mehrbod Vakhshoori
SASaeed Abbasi
Saeed Abbasi
DSdavood shafie
davood shafie
NRNima Rezaei
Nima Rezaei
Background: Novel coronavirus disease 2019 presents with fever, dry cough, fatigue, and shortness of breath in most cases; however, some rare manifestations in other organs have also been reported so far. Case presentation: Here, the case of a 69-year-old Iranian man with coronavirus disease 2019 is presented who suffered from frequent episodes of vasopressor-resistant hypotension during intensive care unit admission, which was finally attributed to the occurrence of acute adrenal insufficiency. Conclusions: As this is a rare complication, adrenal insufficiency might be easily overlooked. However, early detection of this disease among critically ill patients infected with coronavirus disease 2019 could be lifesaving, especially among those unresponsive to vasopressor agents.

18 September 2021 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MHMaryam Heidarpour
Maryam Heidarpour
SBSepideh Bashiri
Sepideh Bashiri
MVMehrbod Vakhshoori
Mehrbod Vakhshoori
KHKiyan Heshmat-Ghahdarijani
Kiyan Heshmat-Ghahdarijani
FKFarbod Khanizadeh
Farbod Khanizadeh
DSdavood shafie
davood shafie
Background: Platelet-to-lymphocyte ratio (PLR) is an inflammation index suggested to have the prognostic capability in heart failure (HF). We sought to investigate the association of PLR with cardiovascular disease (CVD) mortality and creatinine (Cr) rise among Iranian individuals suffering from acute decompensated HF (ADHF).Methods: This retrospective cohort study was in the context of the Persian Registry Of cardioVascular diseasE/Heart Failure (PROVE/HF) study. 405 individuals with ADHF admitted to the emergency department were recruited from April 2019 to March 2020. PLR was calculated by division of platelet to absolute lymphocyte counts and categorized based on quartiles. We utilized the Kaplan–Meier curve to show the difference in mortality based on PLR quartiles. Cr rise was defined as the increment of at least 0.3 mg/dl from baseline. Cox proportional hazard ratio (HR) was used to investigate the association of PLR with CVDs mortality.Results: Mean age of participants was 65.9 ± 13.49 years (males: 67.7%). The mean follow-up duration was 4.26 ± 2.2 months. CVDs mortality or re-hospitalization was not significantly associated with PLR status. Multivariate analysis of PLR quartiles showed a minimally reduced likelihood of CVDs death in 2nd quartile versus the first one (HR 0.40, 95% confidence interval (CI) 0.16–1.01, P = 0.054). Cr rise had no remarkable relation with PLR status in neither model.Conclusion: PLR could not be used as an independent prognostic factor among ADHF patients. Several studies are required clarifying the exact utility of this index.

25 August 2022 in International Journal of Hypertension
Verified
Journal Article
Open access
PDF file
MEMaryam Eghbali
Maryam Eghbali
MAMaedeh Akbari
Maedeh Akbari
KSKimiya Seify
Kimiya Seify
MFMohammad Fakhr
Mohammad Fakhr
MHMaryam Heidarpour
Maryam Heidarpour
AKAlireza Khosravi
Alireza Khosravi
Background. Most of the patients with hypertension (HTN) who undergo medical therapy unaccompanied by psychological and behavioral interventions may not achieve their goal in HTN treatment. Self-care is a key factor in controlling HTN. Given that depression, stress, and anxiety are the most psychological disorders in chronic illnesses. Their impact on self-care, quality of life, and HTN control must be studied more. Methods. We analyzed the difference in medication adherence in 252 patients with low vs. high psychological distress. Also, patients with controlled and uncontrolled HTN were compared according to their psychological distress scores. We further assessed the relation of psychological distress, self-care, and medication adherence with patients’ demographic characteristics. Results. 61.3% of our participants were female with a mean age of 60.6 ± 11.35 and male participants had a mean age of 60.5 ± 11.55. The psychological distress score was significantly higher in women with uncontrolled HTN ( value = 0.044). Also, individuals with controlled HTN tend to have a higher medication adherence score ( value = 0.01) and higher self-care score ( value = 0.033). Hypertensive females had a higher psychological distress score (3.35 ± 2.05) and a lower self-care score (64.05 ± 8.16). There was a positive relationship between age and drug adherence. The self-care score was higher (65.95 ± 7.88) in patients having lower psychological distress levels. Conclusion. A lower psychological distress score can result in better self-care, enhancing the probability of better HTN control; thus, psychological interventions may be necessary for the treatment of HTN. However, more studies are needed to assess the effectiveness of this intervention.

14 September 2021 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
MVMehrbod Vakhshoori
Mehrbod Vakhshoori
MHMaryam Heidarpour
Maryam Heidarpour
NBNiloofar Bondariyan
Niloofar Bondariyan
NSNiyousha Sadeghpour
Niyousha Sadeghpour
ZMZohreh Mousavi
Zohreh Mousavi
Background. Coronavirus disease 2019 (COVID-19) manifestations varied completely from its time of emergence. However, the assessment of adrenal insufficiency (AI) in this pandemic is lacking. In this review, we aimed to evaluate the status of AI among COVID-19-infected individuals. Methods. A systematic literature screening in PubMed/MEDLINE, Scopus, and Web of Science was performed until May 23, 2021. We collected relevant published peer-reviewed studies that reported AI occurrence in patients who suffered from COVID-19. Results. A total of 10 records (cross-sectional studies: 3, N=256, males: 176 (68.7), and case reports: 7, N=7, males: 4 (57.1)) were recruited. The age spectrum ranged from 22 to 96 years. AI was diagnosed with laboratory assessment or radiologic findings. The AI prevalence ranged from 3.1 to as high as 64.3 in different studies. Except for one patient, all other patients were discharged in stable conditions in published case reports. Conclusion. This review indicates that AI occurrence in the COVID-19 pandemic seems quite probable; however, the extent and type (primary, secondary, and functional) need to be clarified yet. Appropriate early diagnostic and therapeutic interventions should be done, especially in critically ill patients, to prevent lethal outcomes.

11 January 2022 in Trends in Cardiovascular Medicine
Verified
Journal Article
Closed access
KMKeivan Mohammadi
Keivan Mohammadi
DSdavood shafie
davood shafie
MVMehrbod Vakhshoori
Mehrbod Vakhshoori
NBNiloofar Bondariyan
Niloofar Bondariyan
HRHassan Rezvanian
Hassan Rezvanian
MHMaryam Heidarpour
Maryam Heidarpour

19 March 2025 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
ASArman Shekarian
Arman Shekarian
SMSadegh Mazaheri-Tehrani
Sadegh Mazaheri-Tehrani
SSSaba Shekarian
Saba Shekarian
MPMelika Pourbazargan
Melika Pourbazargan
MSMahsa Setudeh
Mahsa Setudeh
MHMaryam Heidarpour
Maryam Heidarpour
Although recent studies indicate a high prevalence of subclinical hypothyroidism (SCH) in women with polycystic ovary syndrome (PCOS), the reported prevalence rates vary widely. Therefore, we conducted this study to estimate the pooled prevalence of SCH among women with PCOS. Additionally, emerging evidence suggests that SCH may negatively impact insulin resistance in PCOS. Thus, we examined its effect on insulin resistance indices as our secondary objective. We searched PubMed, Web of Science, Scopus, and Embase from their inception to February 25, 2024. Observational studies reporting the prevalence of SCH among women with PCOS were included. Joanna Briggs Institute’s (JBI) critical appraisal checklist for prevalence studies was adopted for the risk of bias assessment. The random-effects model was employed to estimate the pooled prevalence with its 95% confidence intervals (CI). The weighted mean difference (WMD) was used to compare the insulin resistance indices between PCOS patients with and without SCH. Twenty-nine studies comprising 5765 women with PCOS were included. The meta-analysis demonstrated that 19.7% (95% CI: 16.1%; 23.5%) of women with PCOS have SCH. PCOS patients with SCH had significantly higher HOMA-IR (WMD = 0.78, 95% CI: 0.34; 1.22) and fasting insulin (WMD = 2.38, 95% CI: 0.34; 4.42) levels than those without SCH. Differences in fasting plasma glucose and 2-hour postprandial glucose did not reach statistical significance. This systematic review and meta-analysis found that approximately 20% of women with PCOS have SCH. This underscores the need for regular thyroid function testing in these patients. The prevalence of SCH is influenced by the TSH cut-off used for diagnosis, highlighting the need for establishing a standardized TSH cut-off value. Furthermore, SCH significantly elevates the HOMA-IR index and fasting insulin levels, highlighting its potential impact on insulin resistance. Whether these metabolic changes are clinically important and put these individuals at higher risk of developing type 2 diabetes mellitus and cardiovascular disease requires further investigation. CRD42024510798. Not applicable.